HbA(1c) for Diabetes Screening in Acute Coronary Syndrome: time for a reappraisal of the guidelines?

OBJECTIVE: Diabetes is highly prevalent in individuals with acute coronary syndrome (ACS). Current NICE guidelines recommend diabetes screening of hyperglycaemic patients using a fasting plasma glucose after 4 days from admission. In 2012 the World Health Organisation (WHO) approved the use of HbA(1...

Descripción completa

Detalles Bibliográficos
Autores principales: McCune, C, Maynard, S, McClements, B, Lindsay, JR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Ulster Medical Society 2015
Materias:
Clinical Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642257/
https://www.ncbi.nlm.nih.gov/pubmed/26668415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642257/
https://www.ncbi.nlm.nih.gov/pubmed/26668415

Ejemplares similares